Volpara Health Technologies Ltd (ASX: VHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Volpara Health Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $288.71 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 254.83 million
Earnings per share -0.036
Dividend per share N/A
Year To Date Return 2.71%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Volpara Health Technologies Ltd (ASX: VHT)
    Latest News

    three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
    Share Gainers

    Why Lake Resources, Platinum, Polynovo, and Volpara shares are charging higher

    These ASX shares are charging higher today...

    Read more »

    A group of people gathered around a laptop computer with various expressions of interest, concern and surprise on their faces. All are wearing glasses.
    Opinions

    10 ASX shares I think are buys for 2023

    Numerous ASX shares are looking cheap right now in my view.

    Read more »

    A businessman stacks building blocks.
    Opinions

    If I was 40 and had never invested, here's how I'd aim to build a $500,000 ASX share portfolio

    It’s never too late to start investing, but where do you begin? Here are some ideas.

    Read more »

    Two healthcare workers, a male doctor in the background with a woman in scrubs in the foreground,, smile towards the camera against a plain backdrop.
    Healthcare Shares

    Why I'd invest in these 3 ASX shares to combat this one inflationary megatrend

    An ageing population is providing a tailwind for ASX healthcare shares.

    Read more »

    A couple smile as they look at a pregnancy test.
    Small Cap Shares

    3 ASX shares I think are primed to break out in 2023

    A strong year could be in store for these three names.

    Read more »

    A susccesful person kicks back and relaxes on a comfy chair
    Opinions

    Why I'm buying ASX shares in this once-in-a-lifetime market to try and retire early

    Lower share prices during 2022 have provided the ideal time to pick up cheap opportunities.

    Read more »

    A group of friends throw gold confetti in the air in celebration as they sail on a boat on a river.
    Cheap Shares

    Ballin' on a budget: The best ASX shares to buy for under $5

    Five bucks will barely get you a coffee these days, but what sort of ASX shares can it buy?

    Read more »

    A woman holds her finger to the side of her lips in contemplation as she looks upwards to an array of graphic images of light bulbs above her head, one of which is on and glowing.
    Opinions

    Here's why I think these ASX shares are top ideas to buy right now

    Some ASX shares may have been sold off too much.

    Read more »

    Four people on the beach leap high into the air.
    Healthcare Shares

    Volpara share price leaps 5% following record cash receipts

    Volpara's results appeared to impress investors today.

    Read more »

    A young boy pushes his bicycle uphill on a rocky road. He is wearing a helmet and has his tongue hanging out as though he is making a face to show how exhausted he is.
    Opinions

    Why I think these 2 ASX growth shares could keep marching upwards

    Still down heavily in 2022, here are two ideas that I think could rebound.

    Read more »

    Health workers shake hands and congratulate each other on good news.
    Share Gainers

    This ASX All Ordindaries healthcare share is ripping 17% higher amid a new contract win

    Investors seem to like the contract win from this healthcare player.

    Read more »

    happy investor, share price rise, increase, up
    Growth Shares

    Here's where I'd invest $3,000 into ASX growth shares today

    Some ASX growth shares are looking really good value, in my opinion.

    Read more »

    Frequently Asked Questions

    No, the ASX healthcare share has not yet paid any dividends.

    Volpara listed on 27 April 2016.

    VHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Volpara Health Technologies Ltd

    Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

    Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.

    VHT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $1.14 $0.00 0.00% 539,358 $1.13 $1.14 $1.13
    27 Mar 2024 $1.14 $0.00 0.00% 127,606 $1.13 $1.14 $1.13
    26 Mar 2024 $1.14 $0.00 0.00% 64,750 $1.13 $1.14 $1.13
    25 Mar 2024 $1.14 $0.01 0.88% 664,855 $1.13 $1.14 $1.13
    22 Mar 2024 $1.13 $-0.01 -0.88% 1,412,689 $1.13 $1.13 $1.13
    21 Mar 2024 $1.14 $0.01 0.89% 1,093,007 $1.13 $1.14 $1.13
    20 Mar 2024 $1.13 $0.00 0.00% 84,031 $1.13 $1.14 $1.13
    19 Mar 2024 $1.13 $0.00 0.00% 2,861,710 $1.13 $1.13 $1.13
    18 Mar 2024 $1.13 $0.00 0.00% 531,121 $1.13 $1.13 $1.13
    15 Mar 2024 $1.13 $0.00 0.00% 385,743 $1.13 $1.14 $1.13
    14 Mar 2024 $1.13 $0.00 0.00% 2,037,806 $1.13 $1.14 $1.13
    13 Mar 2024 $1.13 $0.00 0.00% 558,056 $1.13 $1.13 $1.13
    12 Mar 2024 $1.13 $0.00 0.00% 310,599 $1.12 $1.13 $1.12
    11 Mar 2024 $1.12 $0.00 0.00% 503,145 $1.12 $1.13 $1.12
    08 Mar 2024 $1.12 $0.00 0.00% 270,682 $1.13 $1.13 $1.12
    07 Mar 2024 $1.12 $-0.01 -0.88% 137,991 $1.13 $1.13 $1.12
    06 Mar 2024 $1.13 $0.01 0.89% 153,301 $1.12 $1.13 $1.12
    05 Mar 2024 $1.12 $0.00 0.00% 47,579 $1.12 $1.13 $1.12
    04 Mar 2024 $1.12 $0.00 0.00% 182,554 $1.12 $1.13 $1.12
    01 Mar 2024 $1.13 $0.00 0.00% 847,151 $1.13 $1.13 $1.12
    29 Feb 2024 $1.12 $0.00 0.00% 32,406 $1.12 $1.12 $1.12
    28 Feb 2024 $1.12 $0.00 0.00% 1,552,964 $1.12 $1.13 $1.12
    27 Feb 2024 $1.12 $0.00 0.00% 285,243 $1.12 $1.13 $1.12

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    17 Aug 2023 Mark Bouw Issued 450,000 $585,000
    Issue of options.
    02 Jun 2023 Teri Thomas Sell 3,577 $2,546
    On-market trade.
    01 Jun 2023 Teri Thomas Exercise 75,280 $57,213
    Conversion of securities. 150,561 RSUs, As per announcement on 02-06-2023
    01 Jun 2023 Teri Thomas Buy 75,280 $57,213
    Conversion of securities. As per announcement on 02-06-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Roger Allen Non-Executive Director Jun 2010
    Roger was Volpara s first major investor, joined the Board
    prior to FDA approval in June 2010, and was Chair from
    October 2015 to March 2019.
    Roger is a well-known entrepreneur, venture capitalist (VC),
    and social impact investor and philanthropist whose global
    career has spanned over 50 years. He helped pioneer the
    Australian technology industry through the Computer
    Power Group, one of the first Australian-founded tech
    companies to scale globally and subsequently IPO in 1987,
    turning over approx. $1B in today s currency. Following
    the companys acquisition in 1995, he cofounded Allen &
    Buckeridge Pty Ltd, one of the first early-stage VC firms.
    Mr John Dimitrious Pavlidis Non-Executive Director Feb 2015
    John Pavlidis joined the VHT board in February
    2015 and has more than 30 years of experience
    as a senior healthcare executive, CEO, or
    company director in the areas of womens health,
    diagnostic imaging, image analysis and artificial
    intelligence, and cardiovascular therapies.
    Mr Paul Reid Non-Executive DirectorNon-Executive Chairman Mar 2018
    Paul joined the Board in March 2018 and brings extensive
    commercial experience gained across a range of
    technology/Software as a Service businesses.
    He was the founding CEO and Chairman of Figured
    Limited, a fintech SaaS company that provides
    management accounting software to farmers in the
    United States, the United Kingdom ,
    Australia, and New Zealand . Figured was the
    NZ Hi-Tech Startup Company of the Year in 2016 and
    has grown at an incredible pace, funded by private,
    corporate and venture capital (VC) investors.
    Ms Karin Lindgren Non-Executive Director Jan 2020
    Karin joined the Board in 2020. She brings over 35 years
    experience in health information technology as a senior
    technology executive and law firm partner. As one of
    the earliest healthcare technology lawyers in the USA,
    Karin has an in-depth knowledge of data governance,
    data privacy, SaaS, and US healthcare, and has extensive
    professional networks across the IT landscape
    Ms Ann Custin Non-Executive Director Sep 2021
    network of industry contacts from an extensive
    career in healthcare across Europe, the Americas,
    and Asia. Her most recent executive role was with
    Siemens Healthineers, where she served as both CFO
    and board director of Siemens Medical Solutions.
    Prior to this role, Ann served as Chief Operating
    and Financial Officer of Scientx and President &
    CEO of USA Draeger Medical Systems, Inc.
    Ms Teri Thomas Chief Executive OfficerManaging Director Apr 2022
    Teri joined the Board in October 2022. She has a
    long history of executive management in healthcare
    IT ranging from strategy and operations to running
    global sales and marketing teams. This includes a
    20-year career at Epic, a global leader in electronic
    health record (EHR) systems and other software
    solutions used by hospitals and healthcare
    organisations in the United States and internationally
    Mr Mark Bouw Non-Executive Director Jan 2023
    Mr Bouw is a experienced senior healthcare CEO .He is a visiting consultant at Stanford University Graduate Business School Seed Program in the United States and is a visiting mentor for Stanfords Ignite program.
    Mr Craig Hadfield Chief Financial OfficerJoint Company Secretary Mar 2017
    -
    Mr Fred Struve General CounselJoint Company Secretary Oct 2022
    -
    Craig Hadfield Chief Financial OfficerJoint Company Secretary
    -
    Fred Struve General CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 27,534,688 10.84%
    Patagorang Pty Ltd 18,467,848 7.27%
    Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> 16,213,561 6.38%
    Citicorp Nominees Pty Limited 11,830,450 4.66%
    HSBC Custody Nominees (Australia) Limited 8,187,911 3.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 8,154,911 3.21%
    Bnp Paribas Noms (Nz) Ltd <Drp> 7,061,556 2.78%
    Prof Sir Michael Brady 6,619,075 2.61%
    Mr Marcus Sarner 5,980,404 2.35%
    National Nominees Limited 4,728,818 1.86%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient 4,420,193 1.74%
    Sir Martin Francis Wood 3,004,655 1.18%
    Lady Kathleen Audrey Wood 3,004,654 1.18%
    BNP Paribas Noms Pty Ltd <Drp> 2,527,511 0.99%
    Prof Martin Yaffe 1,966,483 0.77%
    Mr John Anthony Dell 1,928,864 0.76%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited 1,917,409 0.75%
    Prof Nico Karssemeijer 1,806,806 0.71%
    Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> 1,519,964 0.60%
    RX HOUSE TRUST PTY LTD 880,758 0.35%

    Profile

    since

    Note